Episode 1378 • • 35:41 - 39:32
1378: Yer Boy Amy
FDA Resignations, Alzheimer's Drug Adjuhelm Controversy
Two top FDA regulators resigned following disagreements with the CDC over the timeline for COVID-19 boosters. The agency also faced internal turmoil after approving the Alzheimer's drug Adjuhelm against the advice of its advisory committee. Further discussion highlights the "revolving door" between regulators and industry, noting former FDA chief Fred Hahn joining a biotech firm and Emer Cooke's history as a pharmaceutical lobbyist before leading the EMA.